We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

4SC Obtains Key Patent for Anti-Cancer Compound Resminostat in China

News   Oct 03, 2012

 
4SC Obtains Key Patent for Anti-Cancer Compound Resminostat in China
 
 
Advertisement
 

RELATED ARTICLES

The Microbiome’s Role in Attacking Cancerous Tumors

News

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

READ MORE

Study Links Sex Biases in Drug Dosage Trials to the Overmedication of Women

News

Women are more likely than men to suffer adverse effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new study.

READ MORE

Washington University COVID-19 Vaccine Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE